Espacio reservado para banners y logos institucionales

SABER UCV >  1) Investigación >  Artículos Publicados > 

> Experimental Leishmaniasis: The glibenclamide-triggered decrease in parasite growth correlates with changes in macrophage features.
Please use this identifier to cite or link to this item: https://saber.ucv.ve/handle/10872/1711

Title: Experimental Leishmaniasis: The glibenclamide-triggered decrease in parasite growth correlates with changes in macrophage features.
Authors: Ponte-Sucre, Alicia
Figarella, Katherine
Moll, Heidrun
Keywords: Macrophages
Infectivity
Glibenclamide
Issue Date: 28-Aug-2012
Series/Report no.: Inmunopharmacology and Immunotoxicology;23: 477-486, 2001
Abstract: Previous studies from our laboratories revealed the susceptibility of Leishmania sp. to glibenclamide (GLIB), a potassium channel blocker which selectively interacts with adenosine-binding-cassette transporters. In the present work, we analyzed whether the drug sensitivity of intracellular amastigotes correlates with changes in macrophage features that are related to their function as antigen-presenting cells. We provide evidence that in BALB/c murine macrophages, GLIB induced a decrease in the interferon-gamma-stimulated expression of major histocompatibility complex class II molecules and the co-stimulatory molecule CD86 (B7-2). Furthermore, it caused a decrease in the interleukin-1 secretion by macrophages. The data indicate that the treatment with GLIB inhibits the Th2 development and polarizes macrophage functions towards the induction of a protective Th1 response.
URI: http://hdl.handle.net/10872/1711
ISSN: 0892-3973
Appears in Collections:Artículos Publicados

Files in This Item:

File Description SizeFormat
Figarella et al.pdf128.88 kBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.